UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
June 8, 2010
Date of Report (date of earliest event reported)
 
 
SENORX, INC.
(Exact name of Registrant as specified in its charter)
 
 
Delaware       001-33382   33-0787406
(State or other jurisdiction of    (Commission File Number)     (I.R.S. Employer
incorporation or organization)        Identification Number)
                                                                                                     
 
3 Morgan, Irvine, California 92618
(Address of principal executive offices)
 
(949) 362-4800
(Registrant’s telephone number, including area code)
 
N/A
( Former name or former address, if changed since last report )
 

 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 
 

Item 5.07.                      Submission of Matters to a Vote of Security Holders.
 
At the SenoRx, Inc. (the “Company”) 2010 Annual Meeting of Stockholders (“Annual Meeting”) held on June 8, 2010, the following individuals were elected by the votes indicated as Class III directors of the Company for terms expiring at the 2013 Annual Meeting of Stockholders:

Nominees
  
Shares For
  
Shares Withheld
  
Broker 
Non-Votes
 
Kim D. Blickenstaff
  
7,223,645
  
56,681
  
4,818,345
 
John T. Buhler
  
7,188,429
  
91,897
  
4,818,345
 
Gregory D. Waller
  
6,858,891
  
421,345
  
4,818,345
 
At the Annual Meeting, stockholders also ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2010. Voting results on this matter were as follows: 11,880,767 shares were voted for ratification; 217,804 shares were voted against ratification; and 100 shares abstained. There were no broker non-votes.
 
 
 
 
 
 

 
 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
SENORX, INC.
 
       
Date:  June 8, 2010 
By:
/s/ Kevin J. Cousins  
    Kevin J. Cousins  
   
Chief Financial Officer,   Vice President, Finance
 
       
 
 
 
 
 
Senorx (MM) (NASDAQ:SENO)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Senorx (MM).
Senorx (MM) (NASDAQ:SENO)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Senorx (MM).